Found 18 clinical trials
A Study to Evaluate the Efficacy, Safety and Tolerability of Combinations Study medication and Mirabegron Compared to Study medication and Mirabegron Monotherapy in the Treatment of Overactive Bladder
A Study to Evaluate the Efficacy, Safety and Tolerability of Combinations Study medication and Mirabegron Compared to Study medication and Mirabegron Monotherapy in the Treatment of Overactive
- 180 views
- 23 Nov, 2020
- 1 location
Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
In previous preclinical studies, our group found that Mirabegron, a clinical drug, could activate brown adipose tissue and inhibit tumor growth in tumour-bearing mice.Investigators look forward
- 0 views
- 07 Apr, 2023
- 1 location
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
To assess the impact of mirabegron versus solifenacin on psychological distress, sexual function, bladder wall thickness and bladder blood flow.
- 0 views
- 19 Sep, 2023
- 1 location
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
The aim of this study is to elucidate whether night-time dosing of mirebegron can improve nocturia, compared with daytime dosing of mirabegron.
- 3 views
- 07 Apr, 2023
- 1 location
Does Mirabegron Increase the Body Heat Generated by the Nervous System
Acute mirabegron administration has been shown to increase brown fat activity in humans. Long-term mirabegron administration upregulates brown fat, and appears to improve glucose regulation, and
- 0 views
- 05 Sep, 2023
- 1 location
Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study
To evaluate the impact of combined therapy on the heart rate variability, compared with monotherapy in women with overactive bladder syndrome. Secondary objective is to evaluate the impact of combined therapy on bladder blood perfusion.
- 0 views
- 20 Sep, 2023
- 1 location
Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults
This is an open-label, 2-Part, phase 1 study to evaluate drug interactions when DA-8010 is co-administered with Paroxetine or Mirabegron in healthy adult subjects
- 0 views
- 30 Aug, 2023
- 1 location
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
Research question: A wealth of existing research has established the independent effectiveness of mirabegron and neuromodulation in the treatment of overactive bladder syndrome
- 0 views
- 22 Mar, 2022
- 1 location
MIrabegron and Physiological Function in Cold Environments
improve cold water tolerance and lower thermal discomfort during cold water diving operations. Mirabegron is a beta-3-adrenergic receptor agonist that is used to treat overactive bladder. Beta-3
- 0 views
- 23 Aug, 2023
- 1 location
- 1
- 2